HealthTree Logo
search more_vert
App Logo
close
person Sign In / Create Account
Off-the Shelf CAR T Cell Therapy Targeting CS1 by Cellectis with David Siegel, MD, PhD, Hackensack University
Off-the Shelf CAR T Cell Therapy Targeting CS1 by Cellectis with David Siegel, MD, PhD, Hackensack University image
HealthTree Podcast for Multiple Myeloma
event May 03, 2019 / 11:00AM - 12:00PM MDT

Event Description

David Siegel, MD, PhD
John Theurer Cancer Center / Hackensack University
Interview Date: May 3, 2019

CAR T cell therapy is making its way into the myeloma clinic. Most of of the early CAR T therapies have been personalized for each patient using a target of BCMA. In this new Phase I study, the CAR T treatment is an off-the-shelf treatment from a donor. The target for this Cellectis treatment is CS1. This study will open this year at several locations and will include patients who have relapsed most of the myeloma drugs, including another CS1 targeted therapy called elotuzumab. Learn more about this fascinating new approach to CAR T therapy from Dr. David Siegel, a leading myeloma researcher at Hackensack University. 

Thanks to our episode sponsor

 

Schedule & Agenda

person
Discussion
11:00AM
Dr. David Siegel & Jenny Ahlstrom

Speakers & Moderators

The panelist Jennifer Ahlstrom
Jennifer Ahlstrom

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of the HealthTree Foundation.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

+1 800 709 1113

email

Support@healthtree.org

Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Janssen Oncology
Adaptive Biotechnologies
Amgen Oncology
Abbvie
Genentech
Bristol Myers Squibb

Follow Us

facebook instagram twitter youtube